When plasma copeptin is tested early in acute stroke, it provides a more accurate prognostic evaluation of acute ischemic stroke severity, according to a systematic review and meta-analysis of several observational studies evaluating the predictive function of copeptin in stroke patients [18]. The gene discussed is AVP; the disease is stroke disorder.